Latest news from Therapeutic Advances in Hematology on 海角社区 en-us Copyright 2025 海角社区 115 31 / /images/newswise-logo-rss.gif /articles/efficacy-and-safety-of-mesenchymal-stem-cells-treatment-for-multidrug-resistant-graft-versus-host-disease-after-haploidentical-allogeneic-hematopoietic-stem-cell-transplantation/?sc=rsin /articles/efficacy-and-safety-of-mesenchymal-stem-cells-treatment-for-multidrug-resistant-graft-versus-host-disease-after-haploidentical-allogeneic-hematopoietic-stem-cell-transplantation/?sc=rsin Mon, 24 Jan 2022 08:55:25 EST Purpose: Graft-versus-host disease (GVHD) is an important complication after human leukocyte antigen (HLA) haploidentical donor (HID) hematopoietic聽stem聽cell transplantation (HSCT), which may lead to poor prognosis. Our study intends to聽... Therapeutic Advances in Hematology